Previous Posts
- EPA Finds a Public Health Emergency in Montana
- Stolen Levemir Insulin may be Dangerous
- F.D.A. Panel Recommends Approval of a Gout Drug
- Recall Issued by Hi-Tech Pharmaceuticals For Undec...
- President Obama to Extend Federal Benefits to Same...
- FDA Takes Steps to Improve Contact Lens Safety
- FDA Issues Warning that Use of Zicam Can Cause Con...
- Skin Cancer Drug Increases Collagen Production and...
- Kid’s Multivitamin Recalled for Label Error
- FDA May Approve a New Gout Drug, Linked to Cardiov...
Click Here to View
Our Other Site
Friday, June 19, 2009
Group Threatens Suit against Bayer for False Advertising Related to One a Day Vitamins
The Center for Science in the Public Interest, a nonprofit group, informed Bayer HealthCare yesterday that the group is planning on suing the company over “deceptive and irresponsible” advertising that contends that selenium in two of Bayer’s multivitamins may reduce men’s risk of prostate cancer. The multivitamins that make those claims are Men’s One a Day and Men’s One a Day 50+ Advantage. David Schardt, the Center’s senior nutritionist, told reporters Thursday that the Center has already filed a complaint with the Federal Trade Commission (FTC).
Trish McKernan, Bayer’s global spokeswoman, responded that the company stands behind that claims that it has made. She stated, "The selenium claims are made by an FDA-approved qualified health claim. We regularly review the evidence, and we change our claims if necessitated. The emerging science hasn't compelled us to change our claims, and the FDA claim is intact."
Bayer promotes One A Day Men's 50+ Advantage and One A Day Men's Health Formula multivitamins on package labels, TV and radio ads and on its Web site. In its promotions, the company says "emerging research" suggests that selenium might reduce the risk of prostate cancer, the Center said.
"Did you know that there are more new cases of prostate cancer each year than any other cancer?" according to one radio ad. "Now there is something you can do."
The Center states that a seven-year, $118 million study funded by the National Institute of Health found last year that selenium does not prevent prostate cancer in men.
For more information, see the article from CNN at: http://www.cnn.com/2009/HEALTH/06/18/bayer.vitamins.lawsuit.cancer/index.html?eref=rss_health
Trish McKernan, Bayer’s global spokeswoman, responded that the company stands behind that claims that it has made. She stated, "The selenium claims are made by an FDA-approved qualified health claim. We regularly review the evidence, and we change our claims if necessitated. The emerging science hasn't compelled us to change our claims, and the FDA claim is intact."
Bayer promotes One A Day Men's 50+ Advantage and One A Day Men's Health Formula multivitamins on package labels, TV and radio ads and on its Web site. In its promotions, the company says "emerging research" suggests that selenium might reduce the risk of prostate cancer, the Center said.
"Did you know that there are more new cases of prostate cancer each year than any other cancer?" according to one radio ad. "Now there is something you can do."
The Center states that a seven-year, $118 million study funded by the National Institute of Health found last year that selenium does not prevent prostate cancer in men.
For more information, see the article from CNN at: http://www.cnn.com/2009/HEALTH/06/18/bayer.vitamins.lawsuit.cancer/index.html?eref=rss_health
Labels: Bayer, Center for Science in the Public Interest, FTC, One a Day, prostate cancer, selenium, Vitamins
posted by
Colleen
at
6:49 AM
<< Home